A dual-action nanomaterial uses cancer’s own chemistry to destroy tumors while leaving healthy cells unharmed.
An international research team with strong participation from DTU has developed a new biotechnological platform that makes it ...
Ovarian cancer kills more women than any other gynecological cancer. Most patients receive their diagnosis only after the ...
A paper published in Biology Methods and Protocols, indicates that a new computational method may help researchers identify ...
FAYETTEVILLE, GA, UNITED STATES, January 15, 2026 /EINPresswire.com/ -- Understanding why cancer cells rely on specific ...
In an effort to foster progress in cancer research, the National Institute of Standards and Technology (NIST) is releasing detailed and comprehensive data about the entire genetic content of a ...
SurvivorNet on MSN
More control, better quality of life: What to know about tarlatamab, the new immunotherapy drug approved for small-cell lung cancer
Tarlatamab (Imdelltra) is a new type of immunotherapy approved for people with small-cell lung cancer whose disease has progressed after chemotherapy and immunotherapy.
Scientists at Oregon State University have developed a new nanomaterial that triggers a pair of chemical reactions inside ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results